CONVINCE in the context of existing evidence on haemodiafiltration
Publication date
2022-05-25
Authors
CONVINCE scientific committee
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Haemodiafiltration (HDF) provides a greater removal of larger solutes and protein-bound compounds than conventional high-flux haemodialysis (HD). There are indications that the patients receiving the highest convection volumes of HDF result in improved survival compared with HD. However, the comparative efficacy of HDF versus HD remains unproven. Here we provide a comparative account of the methodology and aims of 'the comparison of high-dose HDF with high-flux HD' (CONVINCE) study in the context of the totality of evidence and how this study will contribute to reaching a higher level of certainty regarding the comparative efficacy of HDF versus HD in people with end-stage kidney disease.
Keywords
Convection, Hemodiafiltration/methods, Humans, Kidney Failure, Chronic/therapy, Renal Dialysis/methods, Nephrology, Transplantation, Editorial, Research Support, Non-U.S. Gov't
Citation
CONVINCE scientific committee 2022, 'CONVINCE in the context of existing evidence on haemodiafiltration', Nephrol Dial Transplant, vol. 37, no. 6, pp. 1006-1013. https://doi.org/10.1093/ndt/gfac019